ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $620,000 | -30.4% | 21,000 | 0.0% | 0.02% | -9.1% |
Q3 2018 | $891,000 | +3.1% | 21,000 | 0.0% | 0.02% | 0.0% |
Q2 2018 | $864,000 | -32.2% | 21,000 | -4.5% | 0.02% | -40.5% |
Q1 2018 | $1,275,000 | +5.9% | 22,000 | 0.0% | 0.04% | +5.7% |
Q4 2017 | $1,204,000 | +7.7% | 22,000 | 0.0% | 0.04% | +6.1% |
Q3 2017 | $1,118,000 | -12.3% | 22,000 | 0.0% | 0.03% | -21.4% |
Q2 2017 | $1,275,000 | -12.8% | 22,000 | -12.0% | 0.04% | -8.7% |
Q1 2017 | $1,462,000 | +5.2% | 25,000 | 0.0% | 0.05% | +2.2% |
Q4 2016 | $1,390,000 | +18.2% | 25,000 | 0.0% | 0.04% | +36.4% |
Q3 2016 | $1,176,000 | +8.9% | 25,000 | 0.0% | 0.03% | +22.2% |
Q2 2016 | $1,080,000 | +26.3% | 25,000 | 0.0% | 0.03% | +28.6% |
Q1 2016 | $855,000 | -56.9% | 25,000 | 0.0% | 0.02% | -51.2% |
Q4 2015 | $1,984,000 | +35.2% | 25,000 | 0.0% | 0.04% | +59.3% |
Q3 2015 | $1,467,000 | -8.8% | 25,000 | 0.0% | 0.03% | +17.4% |
Q2 2015 | $1,608,000 | +5.5% | 25,000 | 0.0% | 0.02% | +9.5% |
Q1 2015 | $1,524,000 | +4.1% | 25,000 | 0.0% | 0.02% | +5.0% |
Q4 2014 | $1,464,000 | +36.6% | 25,000 | 0.0% | 0.02% | +42.9% |
Q3 2014 | $1,072,000 | -14.8% | 25,000 | 0.0% | 0.01% | -12.5% |
Q2 2014 | $1,258,000 | +14.2% | 25,000 | 0.0% | 0.02% | +14.3% |
Q1 2014 | $1,102,000 | +8.5% | 25,000 | 0.0% | 0.01% | +7.7% |
Q4 2013 | $1,016,000 | +21.0% | 25,000 | 0.0% | 0.01% | +8.3% |
Q3 2013 | $840,000 | +17.2% | 25,000 | 0.0% | 0.01% | +20.0% |
Q2 2013 | $717,000 | – | 25,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
13D Management LLC | 383,584 | $10,023,050 | 5.27% |
Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |